🔍 INSIDER BUY ALERT: Prelude Therapeutics $PRLD
📊 Krishna Vaddi, CEO, purchased 675,000 shares at $0.69 per share, investing $467,438 on March 25, 2025.
Too small of a developmental biotech for me.
Read the full analysis: bit.ly/4217ckk
#InsiderBuying #PRLD #Biotech #DevelopmentalBiotech #SmallCap
0
0
0
0